P1406: SAFETY AND EFFICACY OF IBI346, A FIRST-IN-CLASS BCMA-TARGETING MODULAR CAR-T CELL THERAPY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS FROM TWO PHASE I STUDIES

• Chengcheng Fu,
• Chunrui LI,
• DI Wang,
• Song Jin,
• Weiqin Yao,
• Jingjing Shang,
• Shuang Yan,
• Min Xiao,
• Liting Chen,
• Miao LI,
• Huafeng Wei,
• Jia Duo,
• Lingge Cheng,
• Nana Luo,
• Yongfang Sui,
• Dan Xu,
• Chunyan Yang,
• Lin Zhu,
• Christian Klein,
• Depei Wu

Affiliations

Chengcheng Fu

1 The First Affiliated Hospital of Soochow University, Department of Hematology, China

Chunrui LI

2 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, China

DI Wang

2 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, China

Song Jin

1 The First Affiliated Hospital of Soochow University, Department of Hematology, China

Weiqin Yao

1 The First Affiliated Hospital of Soochow University, Department of Hematology, China

Jingjing Shang

1 The First Affiliated Hospital of Soochow University, Department of Hematology, China

Shuang Yan

1 The First Affiliated Hospital of Soochow University, Department of Hematology, China

Min Xiao

2 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, China

Liting Chen

2 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, China

Miao LI

3 Innovent Cells Pharmaceuticals, China

Huafeng Wei

3 Innovent Cells Pharmaceuticals, China

Jia Duo

3 Innovent Cells Pharmaceuticals, China

Lingge Cheng

4 Innovent Biologics (Suzhou) Co., Ltd., China

Nana Luo

4 Innovent Biologics (Suzhou) Co., Ltd., China

Yongfang Sui

3 Innovent Cells Pharmaceuticals, China

Dan Xu

3 Innovent Cells Pharmaceuticals, China

Chunyan Yang

4 Innovent Biologics (Suzhou) Co., Ltd., China

Lin Zhu

3 Innovent Cells Pharmaceuticals, China

Christian Klein

5 Roche Innovation Center, Switzerland

Depei Wu

1 The First Affiliated Hospital of Soochow University, Department of Hematology, China